Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03057912
Recruitment Status : Unknown
Verified June 2017 by Hu Zheng, First Affiliated Hospital, Sun Yat-Sen University.
Recruitment status was:  Not yet recruiting
First Posted : February 20, 2017
Last Update Posted : June 9, 2017
Jingchu University of Technology
Information provided by (Responsible Party):
Hu Zheng, First Affiliated Hospital, Sun Yat-Sen University